Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study

Publication Date

2026

Content Type

article

PubMed ID:

42341255

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS